1. Home

Program

Filter activities
Auditorium 1
15:00 - 16:10
TUMOR BOARD THYROID CANCER

Tumor Board in the context of the new guidelines

Room 2
15:00 - 16:20
SYMPOSIUM PEDIATRICS & GENETIC DISEASES

Updates on neonatal CH screening

15:00 - 15:20
Metabolomics can be of help?
15:20 - 15:45
Is neonatal diagnosis of Central Hypothyroidism worthy to be implemented?
15:45 - 16:00
The changing spectrum of CH after the loweing of TSH thresholds
16:00 - 16:20
Discussion
Room 3
15:00 - 16:20
SYMPOSIUM REGULATION OF TH M&S

Thyroid hormone action in health and disease

15:00 - 15:20
Structure and function of type 2 and type 3 deiodinase enzymes
15:20 - 15:40
Thyroid hormone in non-alcohholic liver diseases
15:40 - 16:00
Thyroid hormone and muscle differentiation
16:00 - 16:20
Discussion
Room 4
15:00 - 16:20
SYMPOSIUM AUTOIMMUNITY

Advances in role of TSHR

15:00 - 15:20
Advances in structural biology
15:20 - 15:40
TSHR-IGF1R crosstalk
15:40 - 16:00
Utility of TSHR antibodies in clinical practice-Graves'
16:00 - 16:20
Discussion
Room 5
15:00 - 15:50
MEET THE PROFESSOR GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Environmental endocrine disruptors

15:00 - 15:30
Animal Models
15:30 - 15:50
Discussion
Auditorium 1
16:20 - 17:20
HOT ABSTRACTS ABSTRACTS

Hot Abstracts - Clinical

Auditorium 2
16:20 - 17:20
HOT ABSTRACTS ABSTRACTS

Hot Abstracts - Translational

Room 1
16:20 - 17:20
HOT ABSTRACTS ABSTRACTS

Hot Abstracts - Basic

Auditorium 1
17:30 - 19:40
OPENING CEREMONY OPENING CEREMONY

ITC Opening Ceremony - 17th International Thyroid Congress

17:30 - 17:55
Advances in thyroid cancer management (LATS)
17:55 - 18:20
What has changed in Thyroid Eye Disease? (ETA)
18:20 - 18:45
Surgical approach changes in thyroid cancer over the years (ATA)
18:45 - 19:10
Progress in Basic thyroid research: a 5 year overview (AOTA)
Auditorium 1
07:00 - 08:25
EARLY RISER SYMPOSIA THYROID CANCER

Thyroid cancer management: Difficult clinical cases

07:00 - 08:25
Representative for ATA
07:00 - 08:25
Representative for AOTA
07:00 - 08:25
Representative for ETA
07:00 - 08:25
Representative for LATS
Auditorium 1
08:30 - 09:00
PLENARY PLENARY SESSION

30 years of active surveillance for low risk thyroid cancer, lessons learned and future directions

Auditorium 1
09:00 - 09:30
PLENARY PLENARY SESSION

Thyroid hormone analogues and potential applications

Auditorium 1
09:30 - 09:45
POSTER Break

POSTER / EXHIBIT HALL BREAK

Auditorium 1
09:45 - 10:30
LATS PRIZE LECTURE GENERAL

LATS PRIZE LECTURE

Auditorium 1
10:30 - 12:00
DEBATE THYROID & PREGNANCY

TSH threshold for replacement thyroid hormone in pregnancy

10:30 - 10:50
For the proposal
10:50 - 11:10
Against for the proposal
11:10 - 12:00
Discussion
Auditorium 2
10:30 - 11:20
MEET THE PROFESSOR THYROID NODULES

The ATA approach of molecular testing for thyroid nodules

11:10 - 11:20
Discussion
Room 1
10:30 - 11:20
MEET THE PROFESSOR THYROID CANCER

Role of calcitonin measurement in the surgical decision making

11:10 - 11:20
Discussion
Room 2
10:30 - 11:20
MEET THE PROFESSOR PEDIATRICS & GENETIC DISEASES

Pediatric thyroid cancer: Recent advances

11:10 - 11:20
Discussion
Room 3
10:30 - 12:00
DEBATE AUTOIMMUNITY

Is Surgical Treatment Still an Option for Thyroid Eye Disease?

10:30 - 10:50
For the proposal
10:50 - 11:10
Against the proposal
11:10 - 12:00
Discussion
Room 4
10:30 - 11:30
MEET THE PROFESSOR REGULATION OF TH M&S

Thyroid hormone and disease mechanisms

10:30 - 10:50
MCT8 thyroid hormone transporter and disease
10:50 - 11:10
The Leptin-D2 axis controls the energy balance in Skeletal muscle
11:10 - 11:30
Discussion
Room 5
10:30 - 11:30
MEET THE PROFESSOR GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Iodine and nutrition: Global Trends

10:30 - 10:50
WHO task force - new guidelines for monitoring iodine
10:50 - 11:10
State-of-the-Art Guidelines for Monitoring Iodine Nutrition in Populations
11:10 - 11:30
Discussion
Auditorium 1
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Auditorium 1
13:00 - 14:00
SHORT ORAL COMMUNICATIONS GENERAL

SHORT ORAL COMMUNICATIONS

Auditorium 1
14:00 - 14:45
ETA PRIZE LECTURE GENERAL

ETA PRIZE LECTURE

Auditorium 1
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROID CANCER 1

Auditorium 2
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROIDOLOGY 1

Room 1
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - THYROID CANCER BASIC

Room 2
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROIDOLOGY 2

Room 4
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - BASIC THYROIDOLOGY 1

Auditorium 1
15:45 - 16:00
POSTER GENERAL

POSTER SESSION/BREAK IN THE EXHIBIT HALL

Auditorium 1
16:00 - 17:30
SYMPOSIUM THYROID CANCER

Treatment decisions in low risk thyroid cancer

16:00 - 16:25
Indications for Active surveillance
16:25 - 16:50
Less than total thyroidectomy: indications for hemithyroidectomy or RFA
16:50 - 17:15
Dynamic risk stratification, indications for completion thyroidectomy & RAI
17:15 - 17:30
Discussion
Auditorium 2
16:00 - 17:30
SYMPOSIUM THYROID & PREGNANCY

Update on Hyperthyroidism in Pregnancy

16:00 - 16:25
Thyroid storm in pregnancy
16:25 - 16:50
Iodide for the management of hyperthyroidism in pregnancy
16:50 - 17:15
Management in the post-partum
17:15 - 17:30
Discussion
Room 1
16:00 - 17:30
SYMPOSIUM THYROID NODULES

Emerging Trends in Thyroid Nodule Imaging

16:00 - 16:25
Performance of different US classification systems
16:25 - 16:50
Application of AI in thyroid nodule imaging
16:50 - 17:15
Contrast enhance imaging /elastography
17:15 - 17:30
Discussion
Room 2
16:00 - 17:30
SYMPOSIUM REGULATION OF TH M&S

Developmental functions of thyroid hormone

16:00 - 16:25
Thyroid hormone and brain development
16:25 - 16:50
Thyroid hormone transporters and deiodinases in development
16:50 - 17:15
Thyroid hormone and neuronal differentiation in organoids
17:15 - 17:30
Discussion
Room 3
16:00 - 16:50
MEET THE PROFESSOR PEDIATRICS & GENETIC DISEASES

Management of Graves’s disease in children

16:30 - 16:50
Discussion
Room 4
16:00 - 16:50
MEET THE PROFESSOR THYROID DYSFUNCTION

Obesity following treatment for thyroid dysfunction

16:30 - 16:50
Discussion
Room 5
16:00 - 17:30
ROUND TABLE THYROID CANCER

Internacional Round Table - Global challenges in thyroid health

Room 2
18:00 - 19:00
GENERAL ASSEMBLY GENERAL ASSEMBLY

AOTA General Assembly

Auditorium 1
07:00 - 08:25
EARLY RISER SYMPOSIA THYROID NODULES

Challenging clinical cases of Thyroid Nodules

07:15 - 07:30
Representative for ATA
07:30 - 07:45
Representative for ETA
07:45 - 08:00
Representative for AOTA
08:00 - 08:15
Representavive for LATS
Auditorium 1
08:30 - 09:00
PLENARY PLENARY SESSION

Opportunities and challenges of artificial intelligence in healthcare

Auditorium 1
09:00 - 09:30
PLENARY PLENARY SESSION

Modeling human thyroid development and diseases using stem cell-derived organoids

Auditorium 1
09:30 - 09:45
POSTER Break

POSTER / EXHIBIT HALL BREAK

Auditorium 1
09:45 - 11:15
SYMPOSIUM THYROID CANCER

Novel therapeutic perspectives for advanced thyroid cancer

09:45 - 10:10
Advances in Medullary Thyroid Cancer
10:10 - 10:35
Redifferentiation therapy
10:35 - 11:00
Neoadjuvant therapy
11:00 - 11:15
Discussion
Auditorium 2
09:45 - 11:10
DEBATE THYROID NODULES

Controversies for and against routine serum calcitonin measurement and FNA washout in thyroid nodules

09:45 - 10:05
Screening NO
10:05 - 10:25
Screening YES
10:25 - 11:10
Discussion
Room 1
09:45 - 11:15
SYMPOSIUM PEDIATRICS & GENETIC DISEASES

Genetics in congenital Hypothyroidism

09:45 - 10:10
How genetics can modify the management of CH?
10:10 - 10:35
Functional noncoding variants as new cause of CH
10:35 - 11:00
Dealing with variants of uncertain significance in the genetic diagnosis of congenital hypothyroidism
11:00 - 11:15
Discussion
Room 2
09:45 - 10:45
MEET THE PROFESSOR REGULATION OF TH M&S

Transcription and circadian control by thyroid hormone

09:45 - 10:10
Thyroid hormone and genomic regulation in amphibians
10:10 - 10:35
Thyroid hormone and circadian control
10:35 - 10:45
Discussion
Room 3
09:45 - 10:45
MEET THE PROFESSOR REGULATION OF TH M&S

Tissue responses to thyroid hormone

09:45 - 10:10
Patients with THRA and THRB receptor defects
10:10 - 10:35
Thyroid hormone and the immune system
10:35 - 10:45
Discussion
Room 4
09:45 - 10:35
MEET THE PROFESSOR AUTOIMMUNITY

IgG4 related thyroid disease

10:15 - 10:35
Discussion
Room 5
09:45 - 11:15
SYMPOSIUM GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Iodine, selenium and thyroid diseases

09:45 - 10:10
The structure, function, and mechanism of the Na+/I- symporter (NIS)
10:10 - 10:35
Iodine prophylaxis: what has changed for thyroid diseases?
10:35 - 11:00
Selenium and thyroid function: what is new
11:00 - 11:15
Discussion
Room 4
10:35 - 11:25
MEET THE PROFESSOR GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Nuclear accidents and thyroid disease

10:45 - 11:15
The Effects of Radiation Exposure on the Thyroid Gland in Fukushima, Japan
11:15 - 11:25
Discussion
Auditorium 1
11:15 - 12:05
MEET THE PROFESSOR THYROID CANCER

Outcomes in ATC: Is It Evolving into a Treatable Disease?

11:45 - 12:05
Discussion
Auditorium 2
11:15 - 12:05
MEET THE PROFESSOR PEDIATRICS & GENETIC DISEASES

Thyroid nodule management in children

11:45 - 12:05
Discussion
Room 2
11:15 - 12:05
MEET THE PROFESSOR THYROID & PREGNANCY

Hazards of endocrine disruptors in pregnancy

11:45 - 12:05
Discussion
Auditorium 1
13:00 - 14:00
SHORT ORAL COMMUNICATIONS GENERAL

SHORT ORAL COMMUNICATIONS

Auditorium 1
14:00 - 14:45
ATA PRIZE LECTURE GENERAL

ATA PRIZE LECTURE

Auditorium 1
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROID CANCER 2

Auditorium 2
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - CLINICAL THYROIDOLOGY 3

Room 1
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - THYROID NODULES

Room 2
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - PEDIATRIC THYROIDOLOGY

Room 3
14:45 - 15:45
ORAL ABSTRACTS ABSTRACTS

ORAL SESSION - BASIC THYROIDOLOGY 2

Auditorium 1
15:45 - 16:00
POSTER GENERAL

POSTER SESSION/BREAK IN THE EXHIBIT HALL

Auditorium 1
16:00 - 17:30
SYMPOSIUM THYROID NODULES

Alternative approaches to indeterminate nodule management

16:00 - 16:25
Active surveillance for indeterminate thyroid nodules
16:25 - 16:50
Minimally invasive management of thyroid nodules
16:50 - 17:15
Endoscopic surgery
17:15 - 17:30
Discussion
Auditorium 2
16:00 - 17:30
SYMPOSIUM THYROID DYSFUNCTION

End-Organ Effects of Hyperthyroidism

16:00 - 16:25
Heart and vascular risk
16:25 - 16:50
Bones and fracture risk
16:50 - 17:15
Mental health and cognition
17:15 - 17:30
Discussion
Room 1
16:00 - 17:30
SYMPOSIUM THYROID CANCER

Novel Advances in Thyroid Cancer Research

16:00 - 16:25
TERT promoter mutations as a driver of tumor aggression
16:25 - 16:50
Tumor Microenvironment in thyroid cancer differentiation
16:50 - 17:15
The Role of Deiodinases in Thyroid Tumorigenesis
17:15 - 17:30
Discussion
Room 2
16:00 - 17:30
SYMPOSIUM GOITER, IODINE AND OTHER ENVIRONMENTAL FACTORS

Impact of Radiological and Chemical Exposure on Thyroid Health

16:00 - 16:25
Human radiation exposure and thyroid genetic alterations
16:25 - 16:50
Chemical disruptors and neonatal screening
16:50 - 17:15
Endocrine Disruptors in Thyroid Disease
17:15 - 17:30
Discussion
Room 4
16:00 - 16:50
MEET THE PROFESSOR REGULATION OF TH M&S

Current topics in Nonthyroidal Illness Syndrome

16:00 - 16:30
Understanding the mechanisms behind the disorders
16:30 - 16:50
Discussion
Auditorium 1
08:00 - 09:30
EARLY RISER SYMPOSIA THYROID & PREGNANCY

Masterclass: Impact of thyroid disease & pregnancy (Reasons not to panic)

08:00 - 08:20
Maternal hypothyroxinaemia: treat or observe
08:20 - 08:40
Autoimmunity with assisted reproduction
08:40 - 09:00
Uncontrolled Graves' disease
09:00 - 09:20
Treatment of MCT8 Deficiency during Pregnancy
09:20 - 09:30
Discussion
Auditorium 1
09:30 - 10:15
AOTA PRIZE LECTURE GENERAL

AOTA PRIZE LECTURE

Auditorium 1
10:15 - 10:30
POSTER Break

POSTER SESSION/BREAK IN THE EXHIBIT HALL

Auditorium 1
10:30 - 12:00
SYMPOSIUM THYROID NODULES

Indeterminate Nodules: Molecular and Genomic Strategies Across Different Regions

10:30 - 10:50
North America/Canada
10:50 - 11:10
Europe
11:10 - 11:30
Asia
11:30 - 11:50
Latin America
11:50 - 12:00
Discussion
Auditorium 2
10:30 - 12:00
SYMPOSIUM THYROID DYSFUNCTION

What's New in Hypothyroidism? Recent Advances and Insights

10:30 - 10:55
Metabolic and lipid effects
10:55 - 11:20
Thyroid hormone agonists in metabolic liver disease
11:20 - 11:45
Management of refractory hypothyroidism
11:45 - 12:00
Discussion
Room 1
10:30 - 12:00
SYMPOSIUM THYROID CANCER

Genomics of Thyroid Cancer

10:30 - 10:55
Oncocytic thyroid cancer: new lessons from an old tumor
10:55 - 11:20
Clinical utility of micro RNA expression
11:20 - 11:45
Mechanisms of development of drug resistance to targeted therapies
11:45 - 12:00
Discussion
Room 2
10:30 - 12:00
DEBATE AUTOIMMUNITY

Early definitive treatment of Graves' hyperthyroidism is the gold standard

10:30 - 10:50
For the proposal
10:50 - 11:10
Against the proposal
11:10 - 12:00
Discussion
Room 3
10:30 - 12:00
SYMPOSIUM AUTOIMMUNITY

Environmental Factors and Their Impact on Thyroid Autoimmunity

10:30 - 10:55
Selenium and vitamin D in Hashimoto thyroiditis
10:55 - 11:20
Microbiome in thyroid autoimmunity
11:20 - 11:45
Stress and lifestyle in pathogenesis of AITD
11:45 - 12:00
Discussion
Room 4
10:30 - 12:00
SYMPOSIUM REGULATION OF TH M&S

Thyroid Hormone and the nervous system

10:30 - 10:55
Thyroid hormone transport and the CNS
10:55 - 11:20
Deiodinases and brain function
11:20 - 11:45
Thyroid hormone and neuronal differentiation
11:45 - 12:00
Discussion
Auditorium 1
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Auditorium 2
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 1
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 2
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 3
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Room 4
12:00 - 13:00
POSTER Break

POSTER / EXHIBIT HALL BREAK

Auditorium 1
13:00 - 14:00
DEBATE THYROID CANCER

Use of molecular testing for initial treatment decisions in low and intermediate risk thyroid cancers

13:00 - 13:20
YES
13:20 - 13:50
NO
13:50 - 14:00
Discussion
Auditorium 2
13:00 - 13:50
MEET THE PROFESSOR GENERAL

Alternative Management of Malignant thyroid disease including minimal invasive treatments

13:30 - 13:50
Discussion
Room 1
13:00 - 14:30
SYMPOSIUM THYROID & PREGNANCY

Fetal Risks Associated with Thyroid Disorders

13:00 - 13:25
Long-term impact of in utero thyroid hormone exposure
13:25 - 13:50
Hazards of hyperthyroidism and antithyroid drugs
13:50 - 14:15
TRAb and fetal outcome
14:15 - 14:30
Discussion
Room 2
13:00 - 13:50
MEET THE PROFESSOR THYROID DYSFUNCTION

The Dilemma of Subclinical Hyperthyroidism: Treat or Observe?

13:00 - 13:30
Subclinical Hyperthyroidism: Treat or observe?
13:30 - 13:50
Discussion
Room 3
13:00 - 13:50
MEET THE PROFESSOR THYROID CANCER

Approaches to Managing Toxicity in TKI Treatment

13:30 - 13:50
Discussion
Room 4
13:00 - 14:00
MEET THE PROFESSOR REGULATION OF TH M&S

Hypothalamic-pituitary-thyroid axis

13:00 - 13:20
Update on T4 monotherapy and the HPT axis
13:20 - 13:40
Hypothalamic control of the thyroid axis
13:40 - 14:00
Discussion
Room 5
13:00 - 13:50
MEET THE PROFESSOR THYROID DYSFUNCTION

Thyroid dysfunction with Immune Checkpoint inhibitors

13:00 - 13:30
Thyroid dysfunction with Immune Checkpoint inhibitors
13:30 - 13:50
Discussion
Room 4
13:00 - 14:30
IODINE GLOBAL NETWORK IODINE GLOBAL NETWORK

Session I

13:00 - 13:10
Introduction
13:10 - 13:30
Despite major progress, iodine deficiency remains a global health problem in 2025
13:30 - 13:45
The history of the elimination of iodine deficiency disorders in the Americas
13:45 - 14:00
Awareness and capacity building to sustain optimal iodine nutrition in Latin America
14:00 - 14:15
Effects of iodine intake on thyroid autoimmunity
14:15 - 14:30
Iodotyrosines as novel biomarkers for iodine deficiency
Room 4
14:30 - 16:30
IODINE GLOBAL NETWORK IODINE GLOBAL NETWORK

Break

Room 4
16:30 - 18:00
IODINE GLOBAL NETWORK IODINE GLOBAL NETWORK

Session II

16:30 - 16:45
Strengthening design and surveillance of salt iodization to support safe and effective programs on thyroid function
16:45 - 17:00
Not too little, not too much: the Chilean iodine fortification experience
17:00 - 17:15
Iodine nutritional status in Brazil
17:15 - 17:30
Iodine supplementation in pregnancy in Brazil
17:30 - 17:45
The Danish investigation on iodine intake and thyroid disease (DanThyr): history and implications
17:45 - 18:00
Iodine status in Colombia and its possible association with thyroid autoimmunity
Room 1
08:00 - 10:00
ULTRASOUND COURSE ULTRASOUND COURSE

Session 1

08:00 - 08:10
Introduction
08:10 - 08:40
Basic Principles of Thyroid Ultrasound and Device Settings to Optimize Imaging
08:40 - 09:10
Ultrasound of Diffuse Thyroid Disorders
09:10 - 09:40
Challenges in Thyroid Nodule Imaging
09:40 - 10:00
Assessment of Cervical Lymph Nodes
Room 1
10:00 - 10:30
ULTRASOUND COURSE ULTRASOUND COURSE

Break

Room 1
10:30 - 11:50
ULTRASOUND COURSE ULTRASOUND COURSE

Session 2

10:30 - 10:50
Artificial Intelligence for Evaluation of Thyroid Nodules
10:50 - 11:10
Parathyroid Imaging
11:10 - 11:30
Nonthyroid neck pathology
11:30 - 11:50
Techniques to Optimize Fine Needle Aspiration Biopsy
Room 1
11:50 - 13:00
ULTRASOUND COURSE ULTRASOUND COURSE

Break

Room 1
13:00 - 16:00
ULTRASOUND COURSE ULTRASOUND COURSE

Session 3

13:00 - 13:20
Correlation between ultrasound and thyroid cytology
13:20 - 13:40
Patient demos - Examining phisician
13:40 - 16:00
Presentation of clinical cases
Auditorium 2
08:00 - 08:10
KOCHER CONFERENCE KOCHER CONFERENCE

Opening

Auditorium 2
08:10 - 09:30
KOCHER CONFERENCE KOCHER CONFERENCE

First Session

08:10 - 08:30
Navigating uncertainly: advancements in managing indeterminate thyroid nodules
08:30 - 08:45
RFA x MW – Nuances of indications and techniques
08:45 - 09:00
Is thermal ablation safe for malignancies?
09:00 - 09:15
Expanding the indications for thermal ablations
09:15 - 09:30
Q&A
Auditorium 2
09:30 - 10:30
KOCHER CONFERENCE KOCHER CONFERENCE

Second Session

09:30 - 09:50
Effective surveillance strategies for micropapillary thyroid cancer: integrating surgical insight
09:50 - 10:05
Total thyroidectomy x Lobectomy (indications and follow-up
10:05 - 10:20
Defining the best preoperative apporoach for thyroid cancer
10:20 - 10:30
Q&A
Auditorium 2
10:30 - 10:45
KOCHER CONFERENCE KOCHER CONFERENCE

Break

Auditorium 2
10:45 - 11:30
KOCHER CONFERENCE KOCHER CONFERENCE

Third Session

10:45 - 11:00
Medical management of GD: When is the time for RAI?
11:00 - 11:15
Way and when Surgery for GD
11:15 - 11:30
Q&A
Auditorium 2
11:30 - 12:15
KOCHER CONFERENCE KOCHER CONFERENCE

Fourth Session

11:30 - 11:45
Autofluorescence and Parathyroid Vascular Assessment
11:45 - 12:00
Remote thyroid access: breakthroughs and future directions in surgical innovation
Auditorium 2
12:15 - 12:30
KOCHER CONFERENCE KOCHER CONFERENCE

Break

Auditorium 2
12:30 - 13:00
KOCHER CONFERENCE KOCHER CONFERENCE

Lunch with Keynote lecture: Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and poto-operartive findings

Auditorium 2
13:00 - 14:00
KOCHER CONFERENCE KOCHER CONFERENCE

Fifth Session

13:00 - 13:15
Poorly Differentiated Thyroid Cancer – Contemporary Definitions and Management
13:15 - 13:30
Neoadjuvant Therapy for Advanced Disease
13:30 - 13:45
Disparities in Access to Thyroid Care
13:45 - 14:00
Q&A
Auditorium 2
14:00 - 15:45
KOCHER CONFERENCE KOCHER CONFERENCE

Interdisciplinary tumor board: collaborative strategies for thyroid cancer management

Auditorium 2
15:45 - 16:00
KOCHER CONFERENCE KOCHER CONFERENCE

Closing remarks